Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.33 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26238 | 0.83 | — | — | |
| SCHEMBL25507680 | 0.83 | — | — | |
| SCHEMBL28509375 | 0.81 | — | — | |
| SCHEMBL28429143 | 0.76 | CYP3A4 (0.37) | ALDH1A1MAPTCYP19A1CYP24A1CYP3A4 | |
| Zinc Ion SCHEMBL28499447 | 0.75 | HTT (0.33) | ALDH1A1CYP3A4BAZ2BHTT | |
| SCHEMBL28504192 | 0.74 | HTT (0.34) | ALDH1A1MAPTCYP24A1CYP3A4BAZ2B | |
| SCHEMBL28901779 | 0.72 | MAPT (0.38) | ALDH1A1MAPTCYP19A1HTT | |
| Anthracene SCHEMBL7109280 | 0.69 | CYP19A1 (0.44) | ALDH1A1CYP19A1CYP24A1CYP3A4BAZ2B | |
| SCHEMBL10649859 | 0.68 | NFKB1 (0.34) | CYP19A1CYP3A4BAZ2B | |
| SCHEMBL10649865 | 0.68 | NFKB1 (0.34) | CYP19A1CYP3A4BAZ2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102712671-B | Phospholipase, the nucleic acid encoding it and preparation and their method of use | 帝斯曼知识产权资产管理有限公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-101437954-B | The nucleic acid of zymohexase and coding zymohexase and their preparation and application | CARGILL, INC. (US) | 2015-09-09 | — | — | CN | disclosed |
| CN-102088989-B | Glucagon analogs with enhanced solubility and stability in physiological pH buffers | UNIV INDIANA RES & TECH CORP | 2014-11-26 | — | — | CN | disclosed |
| CN-102438652-B | Antibody formulation | MEDIMMUNE LLC | 2014-08-13 | — | — | CN | disclosed |
| CN-1592791-B | Phytases, nucleic acids encoding them and methods of making and using them | VERENIUM CORP | 2012-09-05 | — | — | CN | disclosed |
| CN-101092455-B | Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments | CANBAS CO LTD | 2012-07-04 | — | — | CN | disclosed |
| WO-2008070586-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF PROTEIN MISFOLDING AND PROTEIN AGGREGATION DISEASES | UNIVERSITY OF WASHINGTON (US) | 2008-06-12 | — | — | WO | disclosed |
| CN-100360564-C | Peptides and peptidomimetics having antiproliferative activity and/or enhancing the effect of nucleic acid damaging agents or treatments | CANBAS RES LAB LTD (JP) | 2008-01-09 | — | — | CN | disclosed |
| CN-101092455-A | Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments | CANBAS CO LTD (JP) | 2007-12-26 | — | — | CN | disclosed |
| CN-1674931-A | T cell receptor CDR3 sequences and detection methods | BAYLOR COLLEGE MEDICINE (US) | 2005-09-28 | — | — | CN | disclosed |
| CN-1642978-A | Peptides and peptidomimetics having antiproliferative activity and/or enhancing the effect of nucleic acid damaging agents or treatments | CANBAS RES LAB LTD (JP) | 2005-07-20 | — | — | CN | disclosed |